Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 27-sep-2026 · last seen 27-sep-2026

CISD2 Longevity Pathway

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: 2026 aging-mouse (Western diet) study: oral probiotic strain CL256B, which bioconverts dietary hesperidin to hesperetin, engaged the CISD2 longevity pathway and improved body composition, hepatic steatosis, and grip strength — first in vivo demonstration that a microbiome-delivered flavonoid metabolite can activate CISD2 in a naturally aging mammal, preclinical only. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.
23-sep-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18